Human monoclonal antibodies to her2/neu
CA 2380813 A1 · Owner: Vitale, Laura · Inventors: Deo, Yashwant; Keler, Tibor; Vitale, Laura
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Isolated human monoclonal antibodies and antigen-binding portions thereof which specifically bind to HER2/neu are disclosed. Also disclosed are bi- and multispecific molecules including human monoclonal antibodies and antigenbinding portions thereof which specifically bind to HER2/neu. The human antibodies can be produced in a non-human transgenic animal e.g. a , transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies non-, human transgenic animals and hybridomas which produce the human antibodies and therapeutic and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 25, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 25, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 25, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.